Table 2.

Clinical Characteristics of Adeno-Associated Virus (AAV) Viremia in Hematopoietic Cell Transplant Recipients

Case PatientAge, y (Sex)Underlying Malignancy (Transplant Type)PTD of AAV-Positive Specimen (Viral Load, Copies/mL)Duration of Viral Detection, dClinical Events in Week Before or After AAV DetectionAbnormal Radiographic or Laboratory FindingsGVHD, Grade (Location)Copathogens Detected in Real TimeCopathogens Detected Retrospectively by PCR (Copies/mL)Clinical Outcome and Autopsy Findings
148 (M)CML (allo-MUR)64 (1043); 71 (none detected); 79 (none detected); 87 (<50)Up to 23Admitted to the hospital with shortness of breath and hypoxemiaLLL infiltrate, pancytopenia, hypocellular bone marrow specimen3 (skin, GI tract, liver)BAL specimen showed budding yeast forms and gram-positive cocci; C. glabrata cultured from sputumBAL specimen positive for C. glabrata; BK virus viremia (360 000) and adenovirus viremia (10 032) on d 64Died on d 111 of pulmonary failure; DAD reported as cause of death at autopsy
248 (F)MDSRA (allo-MUR)21 (52.5)<7NoneNone2 (skin, GI tract)NoneLow-level HHV-6 viremia (230) on d 21Died on d 1517 of recurrent refractory anemia with excess blasts; no autopsy report available
340 (F)AML (autologous)77 (<50)<7Admitted to the hospital with dyspneaMultiple patchy LUL and RLL infiltratesNoneBAL and lung biopsy specimens negative for infectious organisms; blood culture positive for StenotrophomonasLow-level HHV-6 viremia (23)a on d 63Died on d 95 of pulmonary failure; autopsy findings included nonspecific destruction of small bronchioles, DAD, and leukemic relapse
418 (M)ALL (allo-MR, second transplant)28 (2571)<7Reported nausea and diarrhea as an outpatient; endoscopy positive for GVHDBilirubin peaked at 9.8 mg/dL with normal transaminase levels3 (skin, GI tract, liver)NoneLow-level HHV-6 viremia (23) on d 28Died on d 297 from P. jiroveci pneumonia and respiratory failure; family declined autopsy
Case PatientAge, y (Sex)Underlying Malignancy (Transplant Type)PTD of AAV-Positive Specimen (Viral Load, Copies/mL)Duration of Viral Detection, dClinical Events in Week Before or After AAV DetectionAbnormal Radiographic or Laboratory FindingsGVHD, Grade (Location)Copathogens Detected in Real TimeCopathogens Detected Retrospectively by PCR (Copies/mL)Clinical Outcome and Autopsy Findings
148 (M)CML (allo-MUR)64 (1043); 71 (none detected); 79 (none detected); 87 (<50)Up to 23Admitted to the hospital with shortness of breath and hypoxemiaLLL infiltrate, pancytopenia, hypocellular bone marrow specimen3 (skin, GI tract, liver)BAL specimen showed budding yeast forms and gram-positive cocci; C. glabrata cultured from sputumBAL specimen positive for C. glabrata; BK virus viremia (360 000) and adenovirus viremia (10 032) on d 64Died on d 111 of pulmonary failure; DAD reported as cause of death at autopsy
248 (F)MDSRA (allo-MUR)21 (52.5)<7NoneNone2 (skin, GI tract)NoneLow-level HHV-6 viremia (230) on d 21Died on d 1517 of recurrent refractory anemia with excess blasts; no autopsy report available
340 (F)AML (autologous)77 (<50)<7Admitted to the hospital with dyspneaMultiple patchy LUL and RLL infiltratesNoneBAL and lung biopsy specimens negative for infectious organisms; blood culture positive for StenotrophomonasLow-level HHV-6 viremia (23)a on d 63Died on d 95 of pulmonary failure; autopsy findings included nonspecific destruction of small bronchioles, DAD, and leukemic relapse
418 (M)ALL (allo-MR, second transplant)28 (2571)<7Reported nausea and diarrhea as an outpatient; endoscopy positive for GVHDBilirubin peaked at 9.8 mg/dL with normal transaminase levels3 (skin, GI tract, liver)NoneLow-level HHV-6 viremia (23) on d 28Died on d 297 from P. jiroveci pneumonia and respiratory failure; family declined autopsy

Abbreviations: ALL, acute lymphocytic leukemia; allo, allogeneic; AML, acute myelogenous leukemia; BAL, bronchoalveolar lavage; C. glabrata, Candida glabrata; CML, chronic myelogenous leukemia; DAD, diffuse alveolar damage; GI, gastrointestinal tract; GVHD, graft versus host disease; HHV-6, human herpesvirus 6; LLL, left lower lobe; LUL, left upper lobe; MDSRA, myelodysplastic syndrome with refractory anemia; MR, matched related; MUR, matched unrelated; PCR, polymerase chain reaction; P. jiroveci, Pneumocystis jiroveci; PTD, posttransplantation day.

a

Limit of detection of the assay is 23 copies/mL [5].

Table 2.

Clinical Characteristics of Adeno-Associated Virus (AAV) Viremia in Hematopoietic Cell Transplant Recipients

Case PatientAge, y (Sex)Underlying Malignancy (Transplant Type)PTD of AAV-Positive Specimen (Viral Load, Copies/mL)Duration of Viral Detection, dClinical Events in Week Before or After AAV DetectionAbnormal Radiographic or Laboratory FindingsGVHD, Grade (Location)Copathogens Detected in Real TimeCopathogens Detected Retrospectively by PCR (Copies/mL)Clinical Outcome and Autopsy Findings
148 (M)CML (allo-MUR)64 (1043); 71 (none detected); 79 (none detected); 87 (<50)Up to 23Admitted to the hospital with shortness of breath and hypoxemiaLLL infiltrate, pancytopenia, hypocellular bone marrow specimen3 (skin, GI tract, liver)BAL specimen showed budding yeast forms and gram-positive cocci; C. glabrata cultured from sputumBAL specimen positive for C. glabrata; BK virus viremia (360 000) and adenovirus viremia (10 032) on d 64Died on d 111 of pulmonary failure; DAD reported as cause of death at autopsy
248 (F)MDSRA (allo-MUR)21 (52.5)<7NoneNone2 (skin, GI tract)NoneLow-level HHV-6 viremia (230) on d 21Died on d 1517 of recurrent refractory anemia with excess blasts; no autopsy report available
340 (F)AML (autologous)77 (<50)<7Admitted to the hospital with dyspneaMultiple patchy LUL and RLL infiltratesNoneBAL and lung biopsy specimens negative for infectious organisms; blood culture positive for StenotrophomonasLow-level HHV-6 viremia (23)a on d 63Died on d 95 of pulmonary failure; autopsy findings included nonspecific destruction of small bronchioles, DAD, and leukemic relapse
418 (M)ALL (allo-MR, second transplant)28 (2571)<7Reported nausea and diarrhea as an outpatient; endoscopy positive for GVHDBilirubin peaked at 9.8 mg/dL with normal transaminase levels3 (skin, GI tract, liver)NoneLow-level HHV-6 viremia (23) on d 28Died on d 297 from P. jiroveci pneumonia and respiratory failure; family declined autopsy
Case PatientAge, y (Sex)Underlying Malignancy (Transplant Type)PTD of AAV-Positive Specimen (Viral Load, Copies/mL)Duration of Viral Detection, dClinical Events in Week Before or After AAV DetectionAbnormal Radiographic or Laboratory FindingsGVHD, Grade (Location)Copathogens Detected in Real TimeCopathogens Detected Retrospectively by PCR (Copies/mL)Clinical Outcome and Autopsy Findings
148 (M)CML (allo-MUR)64 (1043); 71 (none detected); 79 (none detected); 87 (<50)Up to 23Admitted to the hospital with shortness of breath and hypoxemiaLLL infiltrate, pancytopenia, hypocellular bone marrow specimen3 (skin, GI tract, liver)BAL specimen showed budding yeast forms and gram-positive cocci; C. glabrata cultured from sputumBAL specimen positive for C. glabrata; BK virus viremia (360 000) and adenovirus viremia (10 032) on d 64Died on d 111 of pulmonary failure; DAD reported as cause of death at autopsy
248 (F)MDSRA (allo-MUR)21 (52.5)<7NoneNone2 (skin, GI tract)NoneLow-level HHV-6 viremia (230) on d 21Died on d 1517 of recurrent refractory anemia with excess blasts; no autopsy report available
340 (F)AML (autologous)77 (<50)<7Admitted to the hospital with dyspneaMultiple patchy LUL and RLL infiltratesNoneBAL and lung biopsy specimens negative for infectious organisms; blood culture positive for StenotrophomonasLow-level HHV-6 viremia (23)a on d 63Died on d 95 of pulmonary failure; autopsy findings included nonspecific destruction of small bronchioles, DAD, and leukemic relapse
418 (M)ALL (allo-MR, second transplant)28 (2571)<7Reported nausea and diarrhea as an outpatient; endoscopy positive for GVHDBilirubin peaked at 9.8 mg/dL with normal transaminase levels3 (skin, GI tract, liver)NoneLow-level HHV-6 viremia (23) on d 28Died on d 297 from P. jiroveci pneumonia and respiratory failure; family declined autopsy

Abbreviations: ALL, acute lymphocytic leukemia; allo, allogeneic; AML, acute myelogenous leukemia; BAL, bronchoalveolar lavage; C. glabrata, Candida glabrata; CML, chronic myelogenous leukemia; DAD, diffuse alveolar damage; GI, gastrointestinal tract; GVHD, graft versus host disease; HHV-6, human herpesvirus 6; LLL, left lower lobe; LUL, left upper lobe; MDSRA, myelodysplastic syndrome with refractory anemia; MR, matched related; MUR, matched unrelated; PCR, polymerase chain reaction; P. jiroveci, Pneumocystis jiroveci; PTD, posttransplantation day.

a

Limit of detection of the assay is 23 copies/mL [5].

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close